ID

28998

Beschreibung

A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.

Stichworte

Versionen (1)
  1. 20.02.18 20.02.18 -
Rechteinhaber

GlaxoSmithKline (GSK)

Hochgeladen am

20. Februar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518

Englisch

Swelling assessment No.2

2 Formulare  
Report of physical examination and case clinical description
Beschreibung

Report of physical examination and case clinical description

Alias
UMLS CUI-1
C0031809
Date of physical examination
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Was the examination performed by a member of study personnel during the extensive swelling period :
Beschreibung

Examiner

Datentyp

boolean

Alias
UMLS CUI [1]
C0025082
Date when the swelling was first considered to be extensive:
Beschreibung

Date of first extensive swelling

Datentyp

date

Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
If occurring within 24 hours after vaccination, please specify how long after vaccination:
Beschreibung

Date of fist extensive swelling

Datentyp

integer

Maßeinheiten
  • hours
Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
hours
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
Beschreibung

Swelling case description

Datentyp

text

Alias
UMLS CUI [1,1]
C0449437
UMLS CUI [1,2]
C0678257
UMLS CUI [1,3]
C0038999
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Swelling assessment No.2

2 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Date
Item
Date of physical examination
date
C0011008 (UMLS CUI [1])
Examiner
Item
Was the examination performed by a member of study personnel during the extensive swelling period :
boolean
C0025082 (UMLS CUI [1])
Date of first extensive swelling
Item
Date when the swelling was first considered to be extensive:
date
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Date of fist extensive swelling
Item
If occurring within 24 hours after vaccination, please specify how long after vaccination:
integer
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Swelling case description
Item
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
text
C0449437 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
C0038999 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video